Blood test can detect mutations that cause malaria resistance

08/14/2014 | New Scientist

A study in The New England Journal of Medicine based on an analysis of blood samples of 1,240 people being treated for malaria in Southeast Asia and Africa revealed that detecting mutations in the kelch13 gene can quickly identify who has the resistant form of malaria. The study also found that artemisinin therapy can still eliminate even the most resistant form of malaria if a longer course of treatment is done.

View Full Article in:

New Scientist

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC